This Week’s Life Science Headlines

        Litigation
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

Last Week’s Important Life Science Headlines

        Litigation
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

Keep Us Posted: FDA Updates Rules On Changes To Medical Devices

The U.S. Food and Drug Administration has updated its rules regarding how manufacturers of medical devices disclose manufacturing and design changes to previously approved medical devices. The focus of the FDA’s update is on annual reports for Class III devices which are subject to premarket approval. To read the rest of this blog entry, authored by Jesse D. Rutter of Goldberg Segalla, please visit Risky Business: Avoiding Product Liability, Commercial, and Other Litigation.
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

Pennsylvania Supreme Court Opens Door for Negligent Design Claims Against Pharmaceutical Manufacturers

In a decision with significant potential ramifications, the Pennsylvania Supreme Court has issued a ruling that pharmaceutical companies can be held liable for negligence in the design and marketing of drugs, regardless of claims that the drugs had been properly labeled and tested, as well as approved by the U.S. Food and Drug Administration. The ruling, announced January 22nd, upholds an intermediate appellate court decision against a Pfizer, Inc. subsidiary in a wrongful death action involving the diet drug Redux. In its 4-2 decision, the…
Continue reading...

This Week’s Science Headlines

        Litigation
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

This Week’s Life Science Headlines

        Litigation Regulatory
Continue reading...